| 1. |
Tugal-Tutkun I, Urgancioglu M. Bilateral acute depigmentation of the iris[J]. Graefe's Arch Clin Exp Ophthalmol., 2006, 244(6): 742-746. DOI: 10.1007/s00417-005-0137-x.
|
| 2. |
Perone JM, Chaussard D, Hayek G. Bilateral acute iris transillumination (BAIT) syndrome: literature review[J]. Clin Ophthalmol, 2019, 13: 935-943. DOI: 10.2147/OPTH.S167449.
|
| 3. |
Tugal-Tutkun I, Araz B, Taskapili M, et al. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients[J]. Ophthalmology, 2009, 116(8): 1552-1557. DOI: 10.1016/j.ophtha.2009.02.019.
|
| 4. |
Kawali A, Mahendradas P, Shetty R. Acute depigmentation of the iris: a retrospective analysis of 22 cases[J]. Can J Ophthalmol, 2019, 54(1): 33-39. DOI: 10.1016/j.jcjo.2018.03.020.
|
| 5. |
Tuğal-Tutkun İ, Altan Ç. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-an update[J]. Turk J Ophthalmol, 2022, 52(5): 342-347. DOI: 10.4274/tjo.galenos.2022.09552.
|
| 6. |
Lee CC, Lee MT, Chen YS, et al. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone[J]. JAMA Intern Med, 2015, 175(11): 1839-1847. DOI: 10.1001/jamainternmed.2015.5389.
|